CEO Viewpoint: Dr Daniel Tan on future-proofing your lab (and career)

BulletArticle
Q&A with Dr Daniel Tan, CEO of Parkway Laboratories

As CEO of Parkway Laboratory Services (PLS) and Angsana Molecular & Diagnostic Laboratory (AMDL) in Singapore, Dr Daniel Tan has extensive experience in clinical lab management and transformation. In this interview with Lab Insights, he answers questions on a variety of topics, including:

  • [00:07] – current role at PLS and AMDL
  • [01:06] – career journey and learnings along the way
  • [02:30] – approach to quality management and accreditation
  • [03:13] – overall digital strategy
  • [05:08] – use of digital apps to improve patient engagement
  • [05:38] – use of digital apps for lab-clinician collaboration
  • [06:24] – experience with digital health passport technologies
  • [08:07] – precision medicine offerings and plans
  • [08:53] – views on NGS adoption and its benefits
  • [11:13] – strategies for accelerating NGS adoption
  • [12:10] – advice for lab professionals to future-proof their careers in times of rapid change

 

 

Watch the full Q&A below (click the buttons on the play bar to jump to any specific segment that interests you).

동일한 주제에 대한 추가 정보

권장 주제

SequencingRED 2020Rare Diseases
다음 읽기
Scroll to Top